Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-27881House Oversight

Goldman Sachs OTC Derivative Risk Disclosure Document

Other

The passage is a standard risk disclaimer for OTC derivative transactions with Goldman Sachs affiliates. It contains no specific allegations, transactions, dates, or individuals that suggest actionabl Highlights that OTC derivatives with Goldman Sachs cannot be assigned without consent. Notes counterparty credit risk and regulatory differences among Goldman affiliates. Mentions pricing may not be

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #026966
Pages
3
Persons
6
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.